The stock traded at a 52-week high price of Rs 3129.5 and a low of Rs 2311.3.
At 12:40 p.m. M. (IST), the accountant recorded a total trading volume of 2,381 shares with a traded value of Rs 0.74 million, according to Yes.
The stock had closed at Rs 3102.5 in the previous session.
The scrip has advanced 4.54 percent in the last month to date, while the benchmark BSE index Sensex it has gained 2.67 percent during the same period.
According to the stock market data, the shares were trading at a price-earnings multiple (P / E) of 41.3, while the price-to-book ratio stood at 7.37. A higher P / E ratio shows that investors are willing to pay a higher price for the earnings per rupee of stocks due to better expectations for future growth. The book value indicates the inherent value of a company and reflects the price that investors are willing to pay even if there is no growth in a business.
The share belongs to the Pharma industry - India.
Promoter / Holding FII
The promoters had a 71.25% stake in the company as of June 30, 2021, while FII and MF's ownership of the company was 11.65% and 6.66%, respectively.
Key finances
The company reported consolidated sales of Rs 2,174 million for the quarter ended June 30, 2021, 10.02 percent more than the 1976.0 million rupees in the previous quarter and 5.53 percent more than the previous quarter. Rs 2,060 crore from the prior year quarter. Its net profit for the last quarter stood at Rs 330.0 crore, 2.8 percent more than in the same quarter of the previous year.
